BladderPath: For Investigators

 Image Directed Redesign of BladderCancer Treatment Pathways

Change of Staff

If there is a change of staff working on the study please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. Return both documents to the BladderPath Study Office.

Study Documents

Links to the current protocol, patient information sheet, informed consent form are provided below. If there has been a recent amendment to the study please ensure you have R&D approval before using these documents.

Other documents (e.g. amendments, case report form, serious adverse event Form, guidelines, GP Letter etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the BladderPath Study Office.

Version Control Lists

The version numbers and dates of all documents currently used for the study are captured on a document version control lists below:

Case Report Form

Links to the current CRF are provided below.



Other Study Documents


No publications currently.

News and Events

There is no current news or events for this study.

Contact Details

Chief Investigator

Professor Nicholas James                                          
Cancer Centre, 3rd Floor, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH                                              

Tel: 0121 371 3615 or secretary 0121 697 8314
Fax: 0121 371 3602                                                


BladderPath Study Office

Trial Coordinator:                                            Ann Pope
Trial Monitor:                                                   Karen James

Trial Management Team Leader:                 Sarah Bowden
Trial Statistician:                                              Wenyu Liu

Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
B15 2TT


Telphone: +44 (0) 121 414 5102 (9am till 5pm Monday to Friday)
Fax: +44 (0) 121 414 2230

Serious Adverse Event Reporting

Fax: 0121 414 2230    or    0121 414 3700


The University of Birmingham